# A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects

> **NCT03187015** · PHASE1 · COMPLETED · sponsor: **Syndax Pharmaceuticals** · enrollment: 26 (actual)

## Conditions studied

- Drug Interaction
- Healthy Volunteer

## Interventions

- **DRUG:** Entinostat
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03187015
- **Lead sponsor:** Syndax Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-23
- **Primary completion:** 2017-06-04
- **Final completion:** 2017-08-22
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187015, "A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03187015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*